| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AZD6482 | GDSC1000 | pan-cancer | AAC | -0.087 | 0.006 |
| mRNA | Dasatinib | GDSC1000 | pan-cancer | AAC | -0.13 | 0.006 |
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | -0.098 | 0.006 |
| mRNA | PD 153035 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.008 |
| mRNA | JQ-1 | CTRPv2 | pan-cancer | AAC | 0.082 | 0.009 |
| mRNA | BRD-K33199242 | CTRPv2 | pan-cancer | AAC | 0.099 | 0.009 |
| mRNA | staurosporine | CTRPv2 | pan-cancer | AAC | 0.19 | 0.009 |
| mRNA | Bexarotene | GDSC1000 | pan-cancer | AAC | -0.092 | 0.009 |
| mRNA | BX-912 | GDSC1000 | pan-cancer | AAC | -0.078 | 0.009 |
| mRNA | navitoclax:pluripotin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.093 | 0.009 |